8-K: Nuburu Secures $225K, Settles $5.6M Debt via Equity

Nuburu, Inc. announced a $225,000 convertible note issuance and a court-approved settlement to extinguish over $5.6 million in liabilities through equity issuance.

Summary

• Nuburu, Inc. (BURU) issued a $225,000 unsecured, convertible note to Indigo Capital LP on August 18, 2025.
• The note matures on August 17, 2026, and bears no interest unless in default.
• The conversion price for the Indigo Note is 80% of the lowest Volume-Weighted Average Price (VWAP) during the 5 days prior to the conversion date.
• Equity issuance from the Indigo Note is limited to 19.9% of outstanding common stock until stockholder approval, and Indigo cannot hold more than 9.9% of outstanding common stock at any time.
• The Indigo Note is subordinate to the currently outstanding Series A Preferred Stock regarding dividend rights and liquidation distributions.
• The company entered into a court-approved Settlement Agreement with Silverback Capital Corporation (SCC) on July 17, 2025, to resolve outstanding liabilities of at least $5,662,478.57.
• In settlement of these claims, Nuburu will issue freely trading common stock (Settlement Shares) to SCC, exempt from registration under Section 3(a)(10) of the Securities Act.
• An additional 400,000 freely trading shares will be issued to SCC as a Settlement Fee.
• The number of Settlement Shares is determined by dividing the claim amount by the Purchase Price, which is the Closing Price, or a lower adjusted price (75% of Market Price, minimum $0.05) if the stock price declines.
• SCC's beneficial ownership is capped at 4.99% of outstanding common stock, requiring share issuances in tranches.
• As of June 23, 2025, the company had 250,000,000 authorized shares, with approximately 68,960,114 shares issued and outstanding, and 165,629,030 shares available for issuance under the settlement.
• 47,000,000 shares are initially reserved for the settlement, subject to proportional adjustment for reverse stock splits.

Sentiment

Score: 3

Explanation: While the company secured a small capital infusion and settled a significant debt, the terms of both transactions are highly dilutive and indicative of financial distress. The convertible note's floating conversion price and the debt-to-equity settlement's potential for substantial share issuance, coupled with low stock price/volume default triggers, suggest a challenging outlook for existing shareholders. The explicit acknowledgment of significant dilution by management further reinforces a negative sentiment regarding shareholder value.

Positives

• Secured a $225,000 capital infusion from Indigo Capital LP.
• Resolved over $5.6 million in outstanding liabilities through a court-approved settlement, converting debt into equity.
• The settlement shares issued to Silverback Capital Corporation are freely trading and exempt from registration under Section 3(a)(10) of the Securities Act, simplifying the process for the recipient.
• The company's board of directors has approved the dilutive equity issuance, concluding it is in the best interests of the company.

Negatives

• The convertible note to Indigo Capital LP has a conversion price tied to 80% of the lowest VWAP during the 5 days prior to conversion, which could lead to significant dilution if the stock price declines.
• The settlement agreement with Silverback Capital Corporation involves issuing a potentially large, indeterminable number of shares, which could exceed current outstanding shares and cause substantial dilution to existing shareholders.
• The company is obligated to issue shares even if it results in significant dilution, as explicitly stated in the agreement.
• The settlement agreement includes a 'Settlement Fee' of 400,000 shares, adding to the dilutive impact.
• The company faces default conditions if its stock price drops to or below $0.15 or if its 30-day average trading volume drops to or below 1,000,000 shares per day, indicating potential vulnerability to market performance.
• The company is restricted from certain corporate actions (e.g., reverse stock splits, material changes in business/corporate structure, delisting) without court order modification or waiver, or prior public disclosure, for as long as SCC holds shares.

Risks

• Significant Dilution Risk: The issuance of shares under both the Indigo Note (floating conversion price) and the Silverback Capital settlement (floating purchase price, indeterminable number of shares, and a 400,000 share settlement fee) poses a substantial risk of dilution to existing shareholders, potentially exceeding current outstanding shares.
• Stock Price Volatility: The conversion price of the Indigo Note and the purchase price for the settlement shares are tied to the company's stock price, meaning a decline in share price would result in more shares being issued for the same dollar amount, exacerbating dilution.
• Market Performance Default: The company could be declared in default of the settlement agreement if its common stock sale price drops to or below $0.15, or if its 30-day average trading volume drops to or below 1,000,000 shares per day, which could trigger further adverse events or obligations.
• Regulatory Compliance: The company must obtain NYSE approval for a supplemental listing application for the shares to be issued under the settlement, and failure to do so promptly could lead to default.
• Operational Constraints: Covenants in the settlement agreement restrict the company from certain corporate actions (e.g., extraordinary transactions, material asset sales, changes in dividend policy, delisting, SEC registration termination) without specific conditions being met, potentially limiting strategic flexibility.
• Legal and Enforcement Risk: The court reserves jurisdiction for contempt and enforcement of the Settlement Agreement, and the company has agreed to indemnify Silverback Capital Corporation against claims arising from the agreement, including those related to Section 5 of the Securities Act.
• Capital Raise Dependency: The $225,000 capital infusion is relatively small compared to the $5.6 million debt settlement, indicating a continued reliance on equity-based solutions for financial obligations.

Future Outlook

The company anticipates issuing a substantial, currently indeterminable number of shares to settle existing liabilities, acknowledging the potential for significant dilution to current shareholders. Management has concluded that this transaction is in the company's best interest despite the dilutive effect. The company is also committed to maintaining its SEC filings and listing on the NYSE American.

Management Comments

• The Board of Directors of the Company has concluded in its good faith business judgment that such transaction is in the best interests of the Company.
• The Company specifically acknowledges that its obligation to issue the Settlement Shares and Settlement Fee Shares is binding upon the Company and enforceable regardless of the dilution such issuance may have on the ownership interests of other shareholders of the Company.

Industry Context

NA

Corporate Governance

Legal Proceedings

• A civil case in the Circuit Court of the Twelfth Judicial Circuit in and for Manatee County, Florida (CASE NO.: 2025 CA 1576) between Silverback Capital Corporation (Petitioner) and Nuburu, Inc. (Respondents) resulted in an Order Granting Approval of Settlement Agreement and Stipulation and for Declaratory Relief on July 30, 2025.
• The court reserves jurisdiction over the parties for purposes of contempt and enforcement of the Settlement Agreement and Stipulation.

Stakeholder Impact

• Shareholders: Significant potential for substantial dilution due to the issuance of a convertible note with a floating conversion price and the debt-to-equity settlement, which involves issuing an indeterminable number of shares and a 400,000 share settlement fee. Existing shareholders' ownership percentage and per-share value are likely to decrease.
• Creditors (Silverback Capital Corporation): Will receive common stock in exchange for outstanding liabilities, converting debt into equity. This resolves their claims but shifts their exposure to equity risk.
• New Investor (Indigo Capital LP): Provided a $225,000 capital infusion in exchange for a convertible note, with terms that could lead to a significant equity stake at a potentially favorable conversion price.

Next Steps

• Obtain stockholder approval for equity issuance exceeding 19.9% of outstanding common stock related to the Indigo Note.
• Obtain NYSE approval of a supplemental listing application regarding the shares to be issued under the Settlement Agreement.
• Company to file such additional SEC filings as may be required in respect of the transactions.
• Company to increase authorized shares and/or reserve shares if it appears reasonably likely there may be insufficient shares to comply with the Order.
• Silverback Capital Corporation to deliver any remaining shares to the Company for cancellation if the sum of initial and additional issuances exceeds the final amount at the end of the Valuation Period.

Key Dates

Recommendation

The filing reveals a company in a precarious financial state, resorting to highly dilutive financing mechanisms to address both capital needs and significant outstanding liabilities. The $225,000 capital infusion is minor compared to the over $5.6 million in debt being converted to equity. The terms of both the convertible note (80% of lowest VWAP) and the debt settlement (floating purchase price, 400,000 share fee, and explicit acknowledgment of substantial dilution) indicate a willingness to issue a massive number of shares, severely eroding existing shareholder value. Furthermore, the default triggers tied to a low stock price ($0.15) and low trading volume (1M shares/day) suggest the company is already near critical thresholds. The corporate governance restrictions imposed by the settlement agreement also limit future strategic flexibility. For a seasoned investor, these factors point to a high probability of continued share price depreciation due to overwhelming dilution and underlying financial weakness, making it a strong sell.

Keywords

Nuburu, BURU, convertible note, debt settlement, equity issuance, dilution, SEC filing, 8-K, capital raise, Silverback Capital, Indigo Capital, Section 3(a)(10), Section 4(a)(2), corporate governance, financial obligation, stock dilution, NYSE American